US green light for Pfizer/Merck diabetes therapies
admin 2nd January 2018 Uncategorised 0Pfizer and Merck’s diabetes drugs Steglatro and Steglujan have been approved for the US market.
More: US green light for Pfizer/Merck diabetes therapies
Source: News